|
C7ORF11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37879999639878E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.25420000016841E-07 |
| Normal-vs-Stage2 |
6.246300E-02 |
| Normal-vs-Stage3 |
2.249000E-01 |
| Normal-vs-Stage4 |
4.913700E-02 |
| Stage1-vs-Stage2 |
7.098800E-01 |
| Stage1-vs-Stage3 |
1.684220E-01 |
| Stage1-vs-Stage4 |
4.458200E-01 |
| Stage2-vs-Stage3 |
2.580000E-01 |
| Stage2-vs-Stage4 |
8.298200E-01 |
| Stage3-vs-Stage4 |
1.698840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.51999999545794E-08 |
| Normal-vs-AfricanAmerican |
8.766600E-04 |
| Normal-vs-Asian |
3.188200E-01 |
| Caucasian-vs-AfricanAmerican |
9.813800E-01 |
| Caucasian-vs-Asian |
8.440600E-01 |
| AfricanAmerican-vs-Asian |
8.551800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.50880002620136E-09 |
| Normal-vs-Female |
2.799400E-03 |
| Male-vs-Female |
1.186820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.409800E-02 |
| Normal-vs-Extreme_Weight |
1.29739999998879E-06 |
| Normal-vs-Obese |
5.655100E-03 |
| Normal-vs-Extreme_Obese |
3.183700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.154950E-01 |
| Normal_Weight-vs-Obese |
8.886400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.362000E-01 |
| Extreme_Weight-vs-Obese |
9.870400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.798000E-01 |
| Obese-vs-Extreme_Obese |
2.265800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.082800E-03 |
| Normal-vs-Age(41-60Yrs) |
6.98260000042694E-07 |
| Normal-vs-Age(61-80Yrs) |
1.65320999999663E-05 |
| Normal-vs-Age(81-100Yrs) |
4.021200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.446200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.889570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.267760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.380400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.899600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.234000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-16 |
| Normal-VS-Type2 PRCC |
2.729600E-01 |
| Normal-VS-KIRP CIMP |
3.765500E-02 |
| Normal-VS-Unclassified PRCC |
1.978180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.69286806794844E-12 |
| Type1 PRCC-VS-KIRP CIMP |
6.762400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.026800E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.517020E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.290100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.658300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.248400E-02 |
| Normal-vs-N1 |
3.149600E-02 |
| Normal-vs-N2 |
6.557000E-01 |
| N0-vs-N1 |
6.360600E-01 |
| N0-vs-N2 |
3.177400E-01 |
| N1-vs-N2 |
2.092800E-01 |
|
|
